Grand Pharmaceutical pockets HK$1bn from share sale

By Jonathan Breen
03 Aug 2020

China Grand Pharmaceutical and Healthcare Holdings has tapped the equity capital market for HK$1.01bn ($130.9m), boosting its share price over 20% as a result.

The issuer is the latest in a line of Mainland-based healthcare firms to capitalise on the surge in popularity of the sector during the Covid-19 pandemic. Grand Pharma has seen its stock price more than double so far this year.

The firm, with the help of sole placing ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial